Microvascular rarefaction

The goals of this presentation are two-fold: (1) to briefly sketch the field of vascular rarefaction as a key component of various fibrotic diseases and (2) to illustrate it with four vignettes depicting diverse mechanisms of microvascular rarefaction. Specifically, I shall describe migratory and angiogenic incompetence of endothelial cells under conditions of reduced bioavailability of nitric oxide, role of endothelial-to-mesenchymal cell and mesenchymal stem cell-to-endothelial reprogramming and potential role of antiangiogenic peptides in the development of graft vascular disease as exemplified by chronic allograft nephropathy.

[1]  V. Znojil,et al.  Morphometric characteristics of cardiac hypertrophy induced by long-term inhibition of NO synthase. , 1996, Physiological research.

[2]  Natalia Mendelev,et al.  Endothelial-mesenchymal Transformation Chronic Nos Inhibition Actuates , 2006 .

[3]  Youhua Liu.  Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. , 2004, Journal of the American Society of Nephrology : JASN.

[4]  Andrew P. McMahon,et al.  WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature , 2005, Nature.

[5]  Turgay Dalkara,et al.  Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery , 2009, Nature Medicine.

[6]  W. Koch,et al.  Vascular rarefaction in peripheral skeletal muscle after experimental heart failure. , 2003, American journal of physiology. Heart and circulatory physiology.

[7]  J. Hughes,et al.  Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. , 2001, Journal of the American Society of Nephrology : JASN.

[8]  Natalia Mendelev,et al.  Urinary proteomic analysis of chronic allograft nephropathy , 2008, Proteomics. Clinical applications.

[9]  M. Menger,et al.  Microvascular consequences of Kupffer cell modulation in rat liver fibrogenesis , 1999, The Journal of pathology.

[10]  Shawn M. Sweeney,et al.  Endorepellin, a Novel Inhibitor of Angiogenesis Derived from the C Terminus of Perlecan* , 2003, The Journal of Biological Chemistry.

[11]  K. Camphausen,et al.  Endorepellin in vivo: targeting the tumor vasculature and retarding cancer growth and metabolism. , 2006, Journal of the National Cancer Institute.

[12]  Jun Yamashita,et al.  Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors , 2000, Nature.

[13]  A. Bikfalvi,et al.  Tumor angiogenesis , 2020, Advances in cancer research.

[14]  L. E. Watts,et al.  Arteriolar rarefaction in the conjunctiva of human essential hypertensives. , 1978, Microvascular research.

[15]  A. Yeung,et al.  Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year posttransplant. , 1996, Circulation.

[16]  Samuel A. Santoro,et al.  Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through α2β1 integrin , 2004, The Journal of cell biology.

[17]  A. Greene,et al.  Rapid microvessel rarefaction with elevated salt intake and reduced renal mass hypertension in rats. , 1996, Circulation research.

[18]  W. Kilarski,et al.  Biomechanical regulation of blood vessel growth during tissue vascularization , 2009, Nature Medicine.

[19]  B. Folkow.  The fourth Volhard lecture: cardiovascular structural adaptation; its role in the initiation and maintenance of primary hypertension. , 1978, Clinical science and molecular medicine. Supplement.

[20]  M. Frid,et al.  Mature Vascular Endothelium Can Give Rise to Smooth Muscle Cells via Endothelial-Mesenchymal Transdifferentiation: In Vitro Analysis , 2002, Circulation research.

[21]  Lindolfo da Silva Meirelles,et al.  Mesenchymal stem cells reside in virtually all post-natal organs and tissues , 2006, Journal of Cell Science.

[22]  R. Kalluri,et al.  Epithelial-mesenchymal transition and its implications for fibrosis. , 2003, The Journal of clinical investigation.

[23]  H. Kitamura,et al.  Peritubular capillary injury during the progression of experimental glomerulonephritis in rats. , 2000, Journal of the American Society of Nephrology : JASN.

[24]  W. Montagna,et al.  Structural changes in aging human skin. , 1979, The Journal of investigative dermatology.

[25]  J. Folkman,et al.  The sequence of events in the regression of corneal capillaries. , 1978, Laboratory investigation; a journal of technical methods and pathology.

[26]  S. Harper,et al.  Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor , 2005, Diabetologia.

[27]  P. Carmeliet.  Mechanisms of angiogenesis and arteriogenesis , 2000, Nature Medicine.

[28]  M. Goligorsky,et al.  Kidney-derived mesenchymal stem cells contribute to vasculogenesis, angiogenesis and endothelial repair. , 2008, Kidney international.

[29]  Ivar Giaever,et al.  Permissive Role of Nitric Oxide in Endothelin-induced Migration of Endothelial Cells* , 1997, The Journal of Biological Chemistry.

[30]  B. Lévy,et al.  Microvasculature in angiotensin II-dependent cardiac hypertrophy in the rat. , 1998, Hypertension.

[31]  A Bohle,et al.  Significance of tubulointerstitial changes in the renal cortex for the excretory function and concentration ability of the kidney: a morphometric contribution. , 1987, American journal of nephrology.

[32]  N. Kashihara,et al.  Implication of Peritubular Capillary Loss and Altered Expression of Vascular Endothelial Growth Factor in IgA Nephropathy , 2006, Nephron Physiology.

[33]  Z. Ungvari,et al.  The Krebs cycle and mitochondrial mass are early victims of endothelial dysfunction: proteomic approach. , 2009, The American journal of pathology.

[34]  T. Nakagawa,et al.  Nitric oxide modulates vascular disease in the remnant kidney model. , 2002, The American journal of pathology.

[35]  I. Manyonda,et al.  Skin capillary density changes in normal pregnancy and pre-eclampsia , 2002, Journal of hypertension.

[36]  C. Betsholtz,et al.  Pericytes and vascular stability. , 2006, Experimental cell research.

[37]  S. Pillarisetti.  Lipoprotein modulation of subendothelial heparan sulfate proteoglycans (perlecan) and atherogenicity. , 2000, Trends in cardiovascular medicine.

[38]  L. Truong,et al.  Role of the microvascular endothelium in progressive renal disease. , 2002, Journal of the American Society of Nephrology : JASN.

[39]  Ivar Giaever,et al.  Podokinesis in endothelial cell migration: role of nitric oxide. , 1998, American journal of physiology. Cell physiology.

[40]  S M Blinkov,et al.  Rarefication of the arterioles and capillary network in the brain of rats with different forms of hypertension. , 1985, Microvascular research.

[41]  E. Neilson,et al.  Evidence that fibroblasts derive from epithelium during tissue fibrosis. , 2002, The Journal of clinical investigation.

[42]  P. Hutchins,et al.  Decreases in cerebral microvasculature with age are associated with the decline in growth hormone and insulin-like growth factor 1. , 1997, Endocrinology.

[43]  R. Mitchell,et al.  Graft vascular disease: immune response meets the vessel wall. , 2009, Annual review of pathology.

[44]  Lois E. H. Smith,et al.  Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity. , 2003, The Journal of clinical investigation.

[45]  M. Goligorsky,et al.  Indolent course of tubulointerstitial disease in a mouse model of subpressor, low-dose nitric oxide synthase inhibition. , 2008, American journal of physiology. Renal physiology.

[46]  P. Carmeliet,et al.  Angiogenesis in cancer and other diseases , 2000, Nature.

[47]  M. Goligorsky,et al.  Mesenchymal cells from adult kidney support angiogenesis and differentiate into multiple interstitial cell types including erythropoietin-producing fibroblasts. , 2006, American journal of physiology. Renal physiology.

[48]  T. Veikkola,et al.  Interaction of endostatin with integrins implicated in angiogenesis. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[49]  J. T. ter Maaten,et al.  Impaired Skin Capillary Recruitment in Essential Hypertension Is Caused by Both Functional and Structural Capillary Rarefaction , 2001, Hypertension.

[50]  B. Lévy,et al.  Role of microvascular rarefaction in the increased arterial pressure in mice lacking for the endothelial nitric oxide synthase gene (eNOS3pt−/−) , 2002, Journal of hypertension.

[51]  R. Prewitt,et al.  Alterations in the microvasculature of one-kidney, one-clip hypertensive rats. , 1987, The American journal of physiology.

[52]  M. Johnson,et al.  Pressure-independent arteriolar rarefaction in hypertension. , 1991, The American journal of physiology.

[53]  Jean Paul Thiery,et al.  Epithelial-mesenchymal transitions in development and pathologies. , 2003, Current opinion in cell biology.

[54]  A. Hudetz,et al.  Percolation phenomenon: the effect of capillary network rarefaction. , 1993, Microvascular research.

[55]  M. Zeier,et al.  Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure:the effects of ramipril, nifedipine and moxonidine. , 1996, Journal of the American Society of Nephrology : JASN.

[56]  P. Tonellato,et al.  Microvascular rarefaction and tissue vascular resistance in hypertension. , 1989, The American journal of physiology.

[57]  J. Hughes,et al.  Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. , 2001, Journal of the American Society of Nephrology : JASN.

[58]  L. Truong,et al.  A role for uric acid in the progression of renal disease. , 2002, Journal of the American Society of Nephrology : JASN.

[59]  J. Folkman,et al.  Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action. , 2006, Experimental cell research.

[60]  C. Winterford,et al.  Apoptosis occurs in endothelial cells during hypertension-induced microvascular rarefaction. , 1997, Journal of structural biology.

[61]  H. Augustin,et al.  Tension in the vasculature , 2009, Nature Medicine.

[62]  A. Kroon,et al.  Microvascular Abnormalities in Chronic Heart Failure: A Cross‐Sectional Analysis , 2003, Microcirculation.

[63]  P. Carmeliet.  Angiogenesis in health and disease , 2003, Nature Medicine.

[64]  R. Roman,et al.  Reversal of microvascular rarefaction and reduced renal mass hypertension. , 1997, Hypertension.

[65]  Y. Sugisaki,et al.  Peritubular capillary regression during the progression of experimental obstructive nephropathy. , 2002, Journal of the American Society of Nephrology : JASN.

[66]  R. Garrick,et al.  Noninvasive interrogation of microvasculature for signs of endothelial dysfunction in patients with chronic renal failure. , 2004, American journal of physiology. Heart and circulatory physiology.

[67]  Gavin Thurston,et al.  Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system , 2009, Nature Reviews Molecular Cell Biology.

[68]  E. Keshet.  Preventing pathological regression of blood vessels. , 2003, The Journal of clinical investigation.

[69]  M. Goligorsky,et al.  Endothelial dysfunction as a modifier of angiogenic response in Zucker diabetic fat rat: amelioration with Ebselen. , 2004, Kidney international.

[70]  J. Rohen,et al.  Comparative morphological studies on blood vessels in eyes of normotensive and spontaneously hypertensive rats. , 1985, Experimental eye research.

[71]  M. Kunimatsu,et al.  Purification and characterization of perlecan fragment in urine of end-stage renal failure patients. , 1996, Clinica chimica acta; international journal of clinical chemistry.

[72]  Stanley J. Wiegand,et al.  Vascular-specific growth factors and blood vessel formation , 2000, Nature.

[73]  I I Chen,et al.  Development of microvascular rarefaction in the spontaneously hypertensive rat. , 1982, The American journal of physiology.

[74]  M. Goligorsky,et al.  Nitric oxide is necessary for a switch from stationary to locomoting phenotype in epithelial cells. , 1996, The American journal of physiology.

[75]  P. Weismann,et al.  Ultrastructure and histochemistry of rat myocardial capillary endothelial cells in response to diabetes and hypertension , 2005, Cell Research.

[76]  R. Iozzo,et al.  BMP-1/Tolloid-like Metalloproteases Process Endorepellin, the Angiostatic C-terminal Fragment of Perlecan* , 2005, Journal of Biological Chemistry.

[77]  W. Wood,et al.  Prevention of arteriolar rarefaction in the spontaneously hypertensive rat by exposure to simulated high altitude. , 1986, Journal of hypertension.

[78]  William Arbuthnot Sir Lane,et al.  Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.

[79]  A. Ishisaki,et al.  Human Umbilical Vein Endothelium-derived Cells Retain Potential to Differentiate into Smooth Muscle-like Cells* , 2003, The Journal of Biological Chemistry.

[80]  J. Thyberg,et al.  Increased Intimal Hyperplasia and Smooth Muscle Cell Proliferation in Transgenic Mice With Heparan Sulfate–Deficient Perlecan , 2004, Circulation research.

[81]  Markus J Buehler,et al.  Cyclic tensile strain triggers a sequence of autocrine and paracrine signaling to regulate angiogenic sprouting in human vascular cells , 2009, Proceedings of the National Academy of Sciences.

[82]  P. Papanek,et al.  Gender-specific protection from microvessel rarefaction in female hypertensive rats. , 1998, American journal of hypertension.

[83]  T. Meyer,et al.  Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney. , 1995, The Journal of clinical investigation.

[84]  E. Im,et al.  Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells. , 2005, Molecular biology of the cell.

[85]  F. Murad,et al.  Generation and role of angiostatin in human platelets. , 2003, Blood.

[86]  M. Yoshioka,et al.  Regression of the hyaloid vessels and pupillary membrane of the mouse , 1999, Anatomy and Embryology.

[87]  H. Dvorak,et al.  Rous-Whipple Award Lecture. How tumors make bad blood vessels and stroma. , 2003, The American journal of pathology.

[88]  R R Markwald,et al.  Embryonic endothelial cells transdifferentiate into mesenchymal cells expressing smooth muscle actins in vivo and in vitro. , 1997, Circulation research.

[89]  Xueli Yuan,et al.  Endothelial-to-mesenchymal transition contributes to cardiac fibrosis , 2007, Nature Medicine.

[90]  R. Iozzo.  Matrix proteoglycans: from molecular design to cellular function. , 1998, Annual review of biochemistry.

[91]  E. Popa,et al.  Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis. , 2001, The Journal of clinical investigation.